Amoxicillin and Clavulanic Acid
FLEMICLAV 625 is a combination antibiotic that includes Amoxicillin and Clavulanic Acid, used to treat various bacterial infections such as respiratory tract infections, urinary tract infections, and skin infections. This combination enhances efficacy against bacteria that may be resistant to Amoxicillin alone.
FLEMICLAV 625 is formulated with a synergistic combination of Amoxicillin and Clavulanic Acid. Amoxicillin is a penicillin antibiotic that works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxicillin from degradation by certain bacteria. This makes FLEMICLAV 625 effective against a wider range of bacterial infections, including those caused by beta-lactamase producing organisms.
FLEMICLAV 625 is commonly prescribed for:
The formulation allows for convenient dosing and is well-tolerated, making it a preferred choice for many healthcare providers in managing bacterial infections.
FLEMICLAV 625 is indicated for the treatment of:
Dosage Instructions: FLEMICLAV 625 is typically taken every 8 to 12 hours, as prescribed by your healthcare provider. It can be taken with or without food, but taking it with food may help reduce gastrointestinal side effects.
Common side effects associated with FLEMICLAV 625 may include:
Serious Side Effects (rare):
Seek medical attention immediately if any serious side effects occur.
FLEMICLAV 625 should not be used by:
Note: This information is intended for educational purposes and should not replace professional medical advice. Always consult a healthcare provider for appropriate dosing and treatment options.